1194 related articles for article (PubMed ID: 33488618)
1. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.
Shui L; Yang X; Li J; Yi C; Sun Q; Zhu H
Front Immunol; 2019; 10():2989. PubMed ID: 32010123
[TBL] [Abstract][Full Text] [Related]
4. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
5. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
Matson V; Chervin CS; Gajewski TF
Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Cancer of the Host: Colliding Interests.
Baffy G
Adv Exp Med Biol; 2020; 1219():93-107. PubMed ID: 32130695
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.
Wang Y; Ma R; Liu F; Lee SA; Zhang L
Front Immunol; 2018; 9():374. PubMed ID: 29556232
[TBL] [Abstract][Full Text] [Related]
8. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
9. [Carcinogenesis and Gut Microbiota].
Shiotani A; Fukushima S; Matsumoto H
Gan To Kagaku Ryoho; 2019 Feb; 46(2):199-204. PubMed ID: 30914517
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiota influences anticancer immunosurveillance and general health.
Routy B; Gopalakrishnan V; Daillère R; Zitvogel L; Wargo JA; Kroemer G
Nat Rev Clin Oncol; 2018 Jun; 15(6):382-396. PubMed ID: 29636538
[TBL] [Abstract][Full Text] [Related]
12. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.
Jiang S; Ma W; Ma C; Zhang Z; Zhang W; Zhang J
Gut Microbes; 2024; 16(1):2341717. PubMed ID: 38717360
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells.
Anderson R; Theron AJ; Rapoport BL
Front Immunol; 2019; 10():2254. PubMed ID: 31616428
[TBL] [Abstract][Full Text] [Related]
14. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cancer immunotherapy efficacy by gut microbiota.
Huo S; Liu L; Liu J; Li Q; Wang J
Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine.
Wang L; Peng F; Peng C; Du JR
Am J Chin Med; 2021; 49(3):609-626. PubMed ID: 33683187
[TBL] [Abstract][Full Text] [Related]
17. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
18. Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy.
Strouse C; Mangalam A; Zhang J
Gut Microbes; 2019; 10(2):109-112. PubMed ID: 30183502
[TBL] [Abstract][Full Text] [Related]
19. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
20. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
Chen Y; Liu B; Wei Y; Kuang DM
Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
